Evaluation of the Effectiveness of Ultrasonography-Guided Pulsed Radiofrequency to the Suprascapular Nerve in the Treatment of Adhesive Capsulitis in Elderly Patients

NCT ID: NCT07088562

Last Updated: 2025-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-01

Study Completion Date

2025-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Adhesive Capsulitis (AC) is a condition that restricts the passive and active range of motion of the shoulder joint, impairing quality of life and activities. AC, which can be progressive and last a long time, is also called "frozen shoulder." The incidence of AC is 2-4% in the normal patient population. This rate varies between 10-30% in diabetic patients. The limitation and pain in AC joint range of motion (ROM) can last up to 3 years. There is no clear data on its prevalence in elderly patients. Its etiopathogenesis has not been fully elucidated. Fibrotic contractures form in the joint capsule. Diabetes, female gender, autoimmune diseases, thyroid disorders, immobilization, cardiovascular and cerebrovascular diseases, and advanced age are among the risk factors . AC is often diagnosed by physical examination and exclusion of other joint pathologies. Magnetic resonance imaging (MRI) can be helpful in diagnosis .

Physical therapy, medical, interventional methods, and surgery are used in the treatment of AC. In physical therapy, exercises and modalities aimed at increasing ROM are used, while medical treatment includes oral analgesics, myorelaxants, and topical analgesics. Effective treatment options include intra-articular steroid injections and radiofrequency applications for blocking the suprascapular nerve (SN). The SN originates from the ventral branches of the C5-C6 brachial plexus. It is responsible for 70% of the shoulder innervation, particularly to the shoulder joint and capsule, and the acromioclavicular joint (ACJ). It provides motor innervation to the supraspinatus and infraspinatus muscles. NS block or radiofrequency applications are frequently used in the treatment of pain in shoulder joint pathologies, impingement syndrome, and ACJ pathologies. Previously, conventional radiofrequency applied at high temperatures had destructive effects on the nerve. While conventional methods are currently used in some cases, pulsed radiofrequency is effectively applied at lower temperatures, particularly to prevent motor damage .

In this study, we aimed to present the effectiveness of pulsed radiofrequency (SS-PRF) application to the suprascapular nerve in a difficult and challenging patient group (elderly patients) in AC, a difficult disease to treat.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients over the age of 65 who met the diagnostic criteria for AC based on clinical, radiological (MRI), and physical examination between June 2022 and June 2023, but who failed to achieve adequate pain palliation despite appropriate medical and physical therapy modalities, and who underwent SS-PRF treatment will be retrospectively reviewed. Data from the patient files will be recorded for age, gender, body mass index (BMI), symptom duration, affected side, and the presence of concomitant diabetes. Procedure: Under appropriate monitoring conditions, patients who benefited \>50% from the diagnostic block received a single session of SS-PRF at 420°C (45 V, 20 ms) for 240 seconds in a semi-sitting position under ultrasound guidance after obtaining responses from the suprascapular notch with a 100 mm-long, 10 mm active-tip radiofrequency needle.

Patients whose data can be accessed through their files will have their age, gender, body mass index (BMI), symptom duration, painful side, and medical treatments recorded. Activity and Rest Numerical Rating Scale (NRS-11) and Shoulder Pain and Disability Index (SPADI) scores will be recorded before and after treatment, at weeks 4 and 12.

The NRS-11 is an 11-point numerical scale that allows patients to rate their pain from 0 (no pain) to 10 (the most severe pain they have ever experienced).

The SPADI is a validated index consisting of 13 questions, 5 assessing pain and 8 assessing disability, and scored from 0 to 100 to assess shoulder pain and functionality. Higher scores indicate greater pain and disability.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Capsulitis, Adhesive Pulsed Radiofrequency Eldery People Ultrasound Guided Injection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Evaluation of the Effectiveness of Ultrasonography-Guided Pulsed Radiofrequency to the Suprascapular

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over the age of 65 who were diagnosed with adhesive capsulitis through clinical physical examination and imaging and who underwent shoulder SS-PRF.
* Patients with complete data to be scanned in their files.

Exclusion Criteria

Patients with a history of shoulder surgery,

* shoulder impingement syndrome, osteoarthritis, or other primary shoulder pathologies that could explain shoulder pain,
* patients who received shoulder injections within the last 3 months,
* patients with psychosis,
* patients with pacemakers (ICDs), patients with decompensated chronic diseases,
* patients with bleeding disorders,
* patients with active malignancy or infection,
* patients with advanced cervical disc herniation,
* patients with allergies to the medications to be administered,
* patients who could not be communicated with, and patients who did not accept the procedure were excluded from the study.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Halil Ibrahim Altun

pain specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

halil ibrahim altun

Role: PRINCIPAL_INVESTIGATOR

Kanuni Sultan Süleyman Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İKanuni Sultan Süleyman Training and Research Hospital

Küçükçekmece, Istanbul, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Radiofrequency, shoulder pain

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.